Pharma Companies Must Assure Their ‘House Is In Order’ As FTC Takes Aim At Deceptive Endorsements

US FTC sends notices to more than 700 companies about penalties they will face if they use deceptive endorsements and testimonials to promote their products. Industry experts discuss impact of surprising action and cautions to take in teaming up with influencers.

Endorsement
US FTC notifies companies about hefty penalties for deceptive endorsements of their products • Source: Alamy

More from Marketing & Advertising

More from Compliance